A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Recurrent Glioblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California, San Francisco, San Francisco, California, United States
Contact: Study coordinator (John de Groot, MD) · NeuroOncNewPatientCoord@ucsf.edu · 415-353-2193
Saint Luke's Cancer Institute, Kansas City, Missouri, United States
Duke University, Durham, North Carolina, United States
Contact: Study coordinator (Mustafa Khasraw, MD) · mustafa.khasraw@duke.edu · 919-684-5301
Contact: Study coordinator (Monika Anand, PhD) · monika.anand@duke.edu · 9196818838
Contact: Principal Investigator (Mustafa Khasraw, MD)
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Contact: Study coordinator (Howard Colman, MD) · Howard.Colman@hci.utah.edu · 801-646-4090
Contact: Study coordinator (Yuri Kida, MSW) · yuri.kida@hci.utah.edu · 801-646-4397

Study leads

Mustafa Khasraw, MD
Principal Investigator
Duke University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma

Recurrent Glioblastoma

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Recurrent Glioblastoma, IDH-Wildtype · Recurrent MGMT-Methylated Glioblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Duarte, United States

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Glioblastoma (GBM) · High Grade Gliomas · Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Columbus, United States · Edinburgh, United Kingdom

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Glioma · Medulloblastoma · Ependymoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States